Groundbreaking pan-European study by Alpharmaxim and Aston University harnesses behavioural science to uncover factors influencing prescribing practice in Parkinson's Disease and identifies clear opportunities to improve treatment options
ALTRINCHAM, England, July 3, 2025, 03:00 GMT-04
AlpharmaximAstonStudy
Read full article →